drug delivery research News
-
CD Bioparticles Launches Dendrons for Drug Delivery Research
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now introduces a series of dendrons products to support drug delivery research, such as DMPA-G1-Acetylene-NHBOC, DMPA-G1-Azide-NHBoc, and DMPA-G1-Biotin-Carboxyl. They can be used in theranostics, biosensors, optics, adhesives and coatings. CD Bioparticles has expanded its product offering, and ...
-
CD Bioparticles Launches Heparins for Drug Delivery Research
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now introduces a series of Heparins products to support drug delivery research, such as the Heparin Biotin, Heparin Amine, and Heparin Thiol. Researchers can choose Heparins by molecular weight such as 27 kDa, or by functional groups such as Biotin, Amine and Thiol. For example, Heparin Biotin ...
-
CD Bioparticles Releases Prostaglandins to Support Drug Delivery Research
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now introduces a series of prostaglandins products to support drug delivery related research. These new products offer comprehensive choices for researchers, such as Prostaglandin F2a (11beta epimer), Prostaglandin A1, Prostaglandin F1ß, Prostaglandin E2, and Prostaglandin E1-d9. CD ...
-
CD Bioparticles Introduces the Launch of Alginates for Drug Delivery Research
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now introduces a series of alginates products to support drug delivery research. They can be labeled with biotin or functionalized with amine groups, and are for laboratory research use only. Alginates are natural polymers composed of linear copolymers of ß-(1-4)-linked d-mannuronic acid and ...
-
CD Formulation Expands Its Service Portfolio for Drug Delivery Research
As a reliable service provider in pharmaceutical formulation development, CD Formulation constantly expands its service range and today announces to offer a comprehensive portfolio of services for drug delivery system (DDS) research, including microneedle technology services, oral thin films technology services, microencapsulation technology services, liposome drug delivery technology services, ...
-
Exosome Targeting Services at Creative Biolabs Ready to Boost Drug Delivery Research
Exosomes are picking up steam among scientists because they can perform a role in the immune response, antigen presentation, cell migration, cell differentiation, and tumor invasion. Exosomes, which provide a mechanism for macromolecules to be exchanged between cells, play a part in the development of various illnesses, particularly in the modulation of the cancer microenvironment and immune ...
-
Peer reviewed publications reporting the effectiveness of the Kurve intranasal insulin product
Nasaldrugdeliveryblog.com opens lines of communication between drug delivery researchers, device manufacturers. The first blog to address issues related to nasal drug delivery formulation, research, delivery, and devices was launched by Kurve Technology, Inc., a leading developer of nasal drug delivery devices. The blog - http://www.nasaldrugdeliveryblog.com - invites scientists, researchers ...
-
Analyzing Delivery Systems: CD Formulation Introduces In Vitro Testing to Measure Microsphere and Microneedle Release
Researchers and scientists at CD Formulation, a leading pharmaceutical company, have achieved a breakthrough in drug delivery systems with the introduction of an innovative in vitro testing method. This method allows for the precise measurement of release rates for microspheres and microneedles, providing valuable insights for drug formulation and optimizing therapeutic outcomes. By incorporating ...
-
CD Formulation Releases Nanoparticle Development Services for Drug Delivery System Research
With the boom of nanotechnology, a growing number of nanomaterials have been applied to the pharmaceutical industry. For instance, nanoparticle-based drug delivery has become research of interest. More recently, CD Formulation, a trust worthy CRO partner for pharmaceutical companies worldwide, announced its commitment to developing suitable drug carriers by incorporating the power of ...
-
CD Bioparticles Expands Lipid System Portfolio by the Launch of Sphingolipids
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, has now expanded lipid system portfolio and launched a series of Sphingolipids products to support customers' scientific research. CD Bioparticles now offers more choices for researchers to choose from and use in lipid system applications, such as Ceramides, Sphingosines, Sphingomyelin, ...
-
CD Formulation Shows the Ability of Coated Microneedle Preparation Technology for Novel Drug Delivery
Advancements in drug delivery technology have paved the way for more efficient and targeted treatment options. Among these innovations is the development of coated microneedle preparation technology, which has shown promising results in delivering novel drugs to patients. CD formulation involves coated microneedles with specific drug compounds, allowing for controlled and sustained drug delivery. ...
-
BOC Sciences Yields Peptide-siRNA Conjugates of High Quality
BOC Sciences offers synthesis and conjugation of siRNA to the targeted peptide with high quality and yield, hoping to help researchers achieve substantial preclinical progress for RNAi therapeutics. The peptide-siRNA conjugation technology uses peptide as a carrier for nucleic acids to bring short siRNA into the body, thus exerting the gene silencing effect of siRNA specifically toward target ...
By BOC Sciences
-
Pushing the Boundaries of Drug Delivery: CD Formulation's Breakthrough Microsphere and Microneedle Technologies
As medicine continues to advance in this new era, drug delivery methods have been revolutionized to enhance patient comfort, improve treatment outcomes and ensure effective delivery of therapeutic compounds. CD Formulation, a leading pharmaceutical research and development company, has recently unveiled a series of cutting-edge technologies that will further revolutionize and redefine the realm ...
-
CD Bioparticles Announces Magnetofection Reagents for Gene Expression
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, recently introduced a series of Magnetofection Reagents for gene expression. By utilizing the Lipofection and Magnetofection transfection techniques, these reagents are suitable for all types of nucleic acids, including plasmid DNA, linearized DNA, siRNA, oligonucleotides, double-stranded RNA, ...
-
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has launched a new line of Locust Bean Gum with advanced technical platforms to help scientists advance biopharmaceutical research. Over the past few decades, researchers have been working on developing delivery systems that can reduce side effects while improving efficacy. Natural polymers are ...
-
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications. Low dispersion index polymers are polymeric compounds with low molecular weight ...
-
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced an expanded portfolio of Polydimethylsiloxane (PDMS) products, empowering researchers with versatile and biocompatible tools for groundbreaking discoveries. Polydimethylsiloxane is an elastomeric polymer with interesting properties for biomedical applications, including ...
-
Numedico partnership ventures into space to explore novel drug delivery
In keeping with its mission to search beyond what is available today and to strive towards what is possible tomorrow, Numedico Science Pty Ltd, a subsidiary of Numedico Technologies Pty Ltd, has committed to a collaborative partnership with space medtech start-up ResearchSat to explore and expand the development of novel drug delivery methods and therapeutics. As a global participant in the drug ...
-
Numedico partnership ventures into space to explore novel drug delivery
In keeping with its mission to search beyond what is available today and to strive towards what is possible tomorrow, Numedico Science Pty Ltd, a subsidiary of Numedico Technologies Pty Ltd, has committed to a collaborative partnership with space medtech start-up ResearchSat to explore and expand the development of novel drug delivery methods and therapeutics. As a global participant in the ...
-
XPhyto completes Rotigotine transdermal patch optimization and comparative skin absorption study
XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide a product development report on its Rotigotine transdermal (“TDS”) patch. The Company’s Rotigotine patch is based on the TDS platform technology developed by its wholly owned German subsidiary, Vektor Pharma TF GmbH (“Vektor”). Over ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you